| Tecemotide (L-BLP25) versus placebo after chemoradiotherapy for stage III non-small-cell lung cancer (START): a randomised, double-blind, phase 3 trial C Butts, MA Socinski, PL Mitchell, N Thatcher, L Havel, M Krzakowski, ... The lancet oncology 15 (1), 59-68, 2014 | 579 | 2014 |
| Diagnostic and therapeutic guidelines for gastro-entero-pancreatic neuroendocrine neoplasms (recommended by the Polish Network of Neuroendocrine Tumours) B Kos-Kudła, J Blicharz-Dorniak, J Strzelczyk, A Bałdys-Waligórska, ... Endokrynologia Polska 68 (2), 79-110, 2017 | 123 | 2017 |
| Expression of interleukin‐6, interleukin‐6 receptor, and glycoprotein 130 correlates with good prognoses for patients with breast carcinoma A Karczewska, S Nawrocki, D Brȩborowicz, V Filas, A Mackiewicz Cancer: Interdisciplinary International Journal of the American Cancer …, 2000 | 78 | 2000 |
| START: A phase III study of L-BLP25 cancer immunotherapy for unresectable stage III non-small cell lung cancer. CA Butts, MA Socinski, P Mitchell, N Thatcher, L Havel, MJ Krzakowski, ... Journal of Clinical Oncology 31 (15_suppl), 7500-7500, 2013 | 67 | 2013 |
| Genetically modified tumour vaccines–where we are today S Nawrocki, A Mackiewicz Cancer treatment reviews 25 (1), 29-46, 1999 | 65 | 1999 |
| Concurrent chemotherapy and short course radiotherapy in patients with stage IIIA to IIIB non-small cell lung cancer not eligible for radical treatment: results of a randomized … S Nawrocki, M Krzakowski, E Wasilewska-Tesluk, D Kowalski, ... Journal of Thoracic Oncology 5 (8), 1255-1262, 2010 | 39 | 2010 |
| Genetically modified tumour vaccines (GMTV) in melanoma clinical trials S Nawrocki, P Murawa, J Malicki, M Kapcinska, K Gryska, D Izycki, ... Immunology Letters 74 (1), 81-86, 2000 | 37 | 2000 |
| Nowotwory nabłonkowe narządów głowy i szyi A Kawecki, S Nawrocki, W Golusiński, U Grzesiakowska, J Jassem, ... Zalecenia postępowania diagnostyczno-terapeutycznego w nowotworach …, 2013 | 33 | 2013 |
| Genetically modified tumour vaccines: an obstacle race to break host tolerance to cancer S Nawrocki, PJ Wysocki, A Mackiewicz Expert opinion on biological therapy 1 (2), 193-204, 2001 | 31 | 2001 |
| Consensus statement on a screening programme for the detection of early lung cancer in Poland W Rzyman, J Didkowska, R Dziedzic, T Grodzki, T Orłowski, E Szurowska, ... Advances in Respiratory Medicine 86 (1), 53-74, 2018 | 29 | 2018 |
| COVID-19 pandemic: impact on cancer patients M Rucinska, S Nawrocki International Journal of Environmental Research and Public Health 19 (19), 12470, 2022 | 28 | 2022 |
| Complementary and alternative medicine use in hospitalized cancer patients—study from Silesia, Poland K Kasprzycka, M Kurzawa, M Kucharz, M Godawska, M Oleksa, ... International Journal of Environmental Research and Public Health 19 (3), 1600, 2022 | 27 | 2022 |
| Numerical simulations for tumor and cellular immune system interactions in lung cancer treatment M Kolev, S Nawrocki, B Zubik-Kowal Communications in nonlinear science and numerical simulation 18 (6), 1473-1480, 2013 | 27 | 2013 |
| Students’ knowledge about cervical cancer prevention in Poland K Osowiecka, S Yahuza, M Szwiec, A Gwara, K Kasprzycka, M Godawska, ... Medicina 57 (10), 1045, 2021 | 24 | 2021 |
| SHARP hypofractionated stereotactic radiotherapy is well tolerated in prostate cancer: toxicity and quality of life assessment M Rucinska, A Kieszkowska-Grudny, S Nawrocki Strahlentherapie und Onkologie 192, 449, 2016 | 23 | 2016 |
| Clinical study and numerical simulation of brain cancer dynamics under radiotherapy S Nawrocki, B Zubik-Kowal Communications in Nonlinear Science and Numerical Simulation 22 (1-3), 564-573, 2015 | 22 | 2015 |
| The Polish Cancer Anemia Survey (POLCAS): a retrospective multicenter study of 999 cases MZ Wojtukiewicz, E Sierko, M Rybaltowski, E Filipczyk-Cisarz, ... International journal of hematology 89, 276-284, 2009 | 19 | 2009 |
| Ocena jakości życia i strategii radzenia sobie z chorobą w grupie chorych poddanych zabiegowi endoprotezoplastyki stawu biodrowego A Kieszkowska-Grudny, J Maleszewska, A Siwy-Hudowska, S Nawrocki Gerontologia Polska 2, 62-9, 2014 | 15 | 2014 |
| The waiting time of prostate cancer patients in Poland K Osowiecka, S Nawrocki, M Kurowicki, M Rucinska International Journal of Environmental Research and Public Health 16 (3), 342, 2019 | 14 | 2019 |
| How long are cancer patients waiting for oncological therapy in Poland? K Osowiecka, M Rucinska, JJ Nowakowski, S Nawrocki International Journal of Environmental Research and Public Health 15 (4), 577, 2018 | 14 | 2018 |
